Literature DB >> 34811625

Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.

Hinako Nagano1, Shingo Ito1,2, Takeshi Masuda1,2, Sumio Ohtsuki3,4.   

Abstract

PURPOSE: The insulin receptor (INSR) mediates insulin signaling to modulate cellular functions. Although INSR is expressed at the blood-brain barrier (BBB), its role in the modulation of BBB function is poorly understood. Therefore, in this study, we aimed to analyze the effect of INSR knockdown on the expression levels of functional proteins at the BBB.
METHODS: We established the INSR-knockdown cell line (shINSR) using human cerebral microvascular endothelial cells (hCMEC/D3). The cellular proteome was analyzed using quantitative proteomics.
RESULTS: INSR mRNA and protein expressions were decreased in shINSR cells. The suppression of INSR-mediated signaling in shINSR cells was evaluated. The proteins involved in glycolysis and glycogenolysis were suppressed in shINSR cells. As amyloid-β peptide-related proteins, the expressions of presenilin-1 was increased, and those of the insulin-degrading enzyme and neprilysin were decreased. The expressions of BBB transporters, including the ABCB1/MDR1, ABCG2/BCRP, and SLCO2A1/OATP2A1 were significantly decreased by more than 50% in shINSR cells. The efflux activity of ABCB1/MDR1 was also suppressed. The expressions of the low-density lipoprotein receptor-related protein 1 were significantly increased, and those of the transferrin receptor were significantly decreased in shINSR cells. The expression of claudin-5 was also suppressed in shINSR cells.
CONCLUSIONS: The present study suggests that INSR-mediated signaling is involved in the regulation of functional protein expression at the BBB and contributes to the maintenance of BBB function. Changes in the expressions of amyloid-β peptide-related proteins may contribute to the development of cerebral amyloid angiopathy via the suppression of INSR-mediated signaling.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Blood–brain barrier; Brain microvascular endothelial cells; Insulin receptor; Proteomics; Transporter

Mesh:

Substances:

Year:  2021        PMID: 34811625     DOI: 10.1007/s11095-021-03131-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  69 in total

1.  Diabetes mellitus and the risk of dementia: The Rotterdam Study.

Authors:  A Ott; R P Stolk; F van Harskamp; H A Pols; A Hofman; M M Breteler
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 2.  Astrocyte-endothelial interactions at the blood-brain barrier.

Authors:  N Joan Abbott; Lars Rönnbäck; Elisabeth Hansson
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

Review 3.  Elucidation of mechanism of blood-brain barrier damage for prevention and treatment of vascular dementia.

Authors:  Masaki Ueno
Journal:  Rinsho Shinkeigaku       Date:  2017-02-22

4.  Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

Authors:  Harm J van de Haar; Saartje Burgmans; Jacobus F A Jansen; Matthias J P van Osch; Mark A van Buchem; Majon Muller; Paul A M Hofman; Frans R J Verhey; Walter H Backes
Journal:  Radiology       Date:  2016-05-31       Impact factor: 11.105

5.  Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity.

Authors:  J Lou; M Chofflon; C Juillard; Y Donati; N Mili; C A Siegrist; G E Grau
Journal:  Neuroreport       Date:  1997-02-10       Impact factor: 1.837

Review 6.  Diabetes and Alzheimer's disease crosstalk.

Authors:  David Baglietto-Vargas; Jessica Shi; Devin M Yaeger; Rahasson Ager; Frank M LaFerla
Journal:  Neurosci Biobehav Rev       Date:  2016-03-09       Impact factor: 8.989

7.  Quantitative measurements of capillary transport in human brain tumors by computed tomography.

Authors:  D R Groothuis; F J Vriesendorp; B Kupfer; P C Warnke; G D Lapin; A Kuruvilla; N A Vick; M A Mikhael; C S Patlak
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 8.  The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Authors:  Praveen Ballabh; Alex Braun; Maiken Nedergaard
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

Review 9.  Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Authors:  Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2016-04-01       Impact factor: 17.088

Review 10.  Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.

Authors:  Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.